1. Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report. (4th May 2018) Authors: Naqash, Abdul Rafeh; Yang, Li V.; Sanderlin, Edward J.; Atwell, Druid C.; Walker, Paul R. Journal: Acta oncologica Issue: Volume 57:Number 5(2018) Page Start: 705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗